Malonaldehyde and Erythrocyte Antioxidant Status in Children with Controlled Asthma by Roberta Petlevski et al.
Coll. Antropol. 33 (2009) 4: 1251–1254
Original scientific paper
Malonaldehyde and Erythrocyte Antioxidant
Status in Children with Controlled Asthma
Roberta Petlevski1, Irena @untar2, Slavica Dodig3, Mirjana Turkalj4, Ivana ^epelak1,
Jasmina Vojvodi}1, Mario Si~aja5 and Sa{a Missoni6
1 Department of Medical Biochemistry and Haematology, Faculty of Pharmacy and Medical Biochemistry, University of Zagreb,
Zagreb, Croatia
2 Department of Analytical Toxicology, Faculty of Pharmacy and Medical Biochemistry, University of Zagreb, Zagreb, Croatia
3 Department of Clinical Laboratory Diagnosis, Reference Centre for Clinical Allergology of the Ministry of Health and Social
Welfare, Zagreb, Croatia
4 Children’s Hospital Srebrenjak, Reference Centre for Clinical Allergology of the Ministry of Health and Social Welfare, Zagreb,
Croatia
5 Department of Internal Medicine, University Hospital Dubrava, Zagreb, Croatia
6 Institute for Antropological Research, Zagreb, Croatia
A B S T R A C T
In the pathogenesis of asthma, oxidative stress appears to play an important role and existence of an oxidant/antioxi-
dant imbalance is evident. In this study the key markers of oxidative stress and lipid peroxidation in the pathogenesis of
asthma in childhood in comparison to healthy subjects were investigated. Plasma marker of the lipid peroxidation:
malondialdehyde (MDA), the erythrocytes antioxidative enzymes: glutathione peroxidase (GSH-Px), superoxide dismu-
tase (SOD), glutathione reductase (GR) and cysteine-containing tripeptide glutathione (GSH) were evaluated by spectro-
photometric methods using blood samples collected from 37 healthy children and 44 asthmatic patients. The GSH-Px ac-
tivity was significantly lower in asthmatic children (3.99±1.0 IU/g Hb) than in healthy controls (4.61±1.3 IU/g Hb;
p<0.034). Significant difference in activity of the SOD, GR, and concentration of cysteine-containing tripeptide GSH
was not confirmed (p>0.05). Lower GSH-Px activity in children with controlled asthma showed deficient erythrocyte an-
tioxidant defence and evidence of association between oxidative stress and asthma in childhood. Preserved activity of GR
and SOD, together with concentration of GSH and MDA, still seems to be crucial in controlling antioxidant/oxidant bal-
ance of the disease.
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Introduction
Asthma is a chronic inflammatory airway disease
which is the most common chronic disease in the child-
hood in developed countries, with an increasing preva-
lence in the last few decades1.
In the pathogenesis of asthma, oxidative stress ap-
pears to play an important role. There is a growing evi-
dence of an oxidant/antioxidant imbalance. In asthma,
bronchial obstruction is associated with an increased
spontaneous and stimulus – induced production of reac-
tive oxygen species (ROS) such as superoxide radical, hy-
drogen peroxide, and hydroxyl radical2.
ROS are associated with many pathophysiologic chan-
ges that are relevant in asthma, such as increased lipid
peroxidation, increased airway reactivity and secretions,
increased production of chemoatractants, and increased
vascular permeability. Also, oxygen radicals that are not
neutralized by the antioxidant defence react with poly-
unsaturated fatty acid residues in phospholipids, result-
ing in the production of reactive aldehydes. The most
abundant of these is malondialdehyde (MDA)3,4.
The organism, especially lung and blood are endowed
with numerous antioxidants, including glutathione pero-
xidase (GSH-Px), superoxide dismutase (SOD), gluta-
thione (GSH), glutathione reductase (GR), to counter the
oxidant – mediated toxicity. On the other hand, changes
in antioxidant defences have been reported, including de-
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creased GSH-Px in whole blood, and a deficiency of
selenium5. GSH-Px also plays an important role in the
detoxification of various hydroperoxides6.
There is consistent evidence that oxidative stress is
associated with asthma, but until now in research litera-
ture are very little data about oxidative stress and lipid
peroxidation in asthma of childhood7–9.
The house dust mite Dermatophagoides pteronyssi-
nus is one of the most significant indoor sensiting agents
of allergy10.
House-mite allergy is a hypersensitivity reaction to
proteins excreted by dust-mites. In susceptible individu-
als these proteins, have been shown to be associated with
asthma and other allergic diseases11.
The aim of this study was to investigate the antioxi-
dant enzymatic activities and concentration of MDA and
GSH in controlled asthma in childhood in comparison to
healthy subjects, there is reason to believe that there is




In this study analyzed antioxidant status and marker
of lipid peroxidation, MDA, were performed in samples
divided into two groups, patients of asthma and healthy
controls. The control group consists of 37 healthy chil-
dren included 19 girls and 18 boys with a X±SD age of
10.5±4.7 years. The study population consisted of 44 chil-
dren with asthma included 16 girls and 28 boys with a
X±SD age of 10.7±3.6 years. Studied groups of children
were age-gender related.
The present study included children suffering from
allergic asthma who were monosensitized to house dust
mite (Dermatophagoides pteronyssinus) allergen. Inclu-
sion criteria were: a) age 5–16 years, b) a clinical history
of allergic persistent asthma according to the criteria rec-
ommended by the PRACTALL12 and GINA 200713, c)
positive skin pick test to Dermatophagoides pterony-
ssinus, d) increased serum total IgE14, e) specific IgE to
Dermatophagoides pteronyssinus 17.1 kIU/L (Pharma-
cia CAP system, Pharmacia Diagnostics AB, Uppsala,
Sweden), f) baseline FEV1/FVC<predicted and FEV1
<70% of predicted (FEV1=forced expiratory volume in
one second, FVC=and forced vital capacity.
All patients underwent specific immunotherapy to
Dermatophagoides pteronyssinus (Croatian national stan-
dard, partially purified Der p extract, Imunolo{ki zavod,
Zagreb, Croatia)15. During the preceding three months
patients were on their regular controller therapy (in-
haled corticosteroids, ICS or ICS plus long-acting b2-ago-
nists). At the time of investigation patient group had
conrolled asthma (based on daytime/nocturnal symp-
toms, FEV180%, need for reliever and limitations of
daily activities).
Control group included healthy children without clin-
ical signs and symptoms of neither allergic disease nor
acute or chronic disease.
Diagnostic work-up was performed according to stan-
dardized procedure, and in line with ethical principles
and Declaration on Human Rights from Helsinki 1975
and Tokyo amendments 200416.
All study procedures were performed in accordance
with a protocol previously approved by the Ethics Com-
mittee of Children Hospital Srebrnjak, Zagreb. All par-
ents provided written informed consent for the study
procedures.
Sample collection
Plasma peripheral blood samples were drown into
EDTA-containing tubes after 12h fast, by venipuncture.
After centrifugation, the plasma was removed and frozen
at –80 °C. Erythrocytes were washed three times with
0.9% NaCl and lysed in ultra pure water. The super-
natant obtained from lysed erythrocytes was stored at
–80 °C until use.
Malondialdehyde (MDA) was measured in plasma but
superoxide dismutase (SOD, EC 1.15.1.1), glutathione
peroxidase (GSH-Px, EC 1.11.1.9), glutathione reductase
(GR, EC 1.6.4.2) were determined on erythrocyte lysate,
and glutathione (GSH) levels were determined on eryth-
rocyte lysate after precipitation of proteins, using Ell-
man's reagent.
Laboratory assay techniques
The plasma MDA level was determined using the
method based on the reaction with thiobarbituric acid
(TBA) at 90–100 °C17. In the TBA test reaction, MDA or
MDA-like substances and TBA react together producing
of a pink pigment having an absorption maximum at 532
nm. The sample was mixed with cold 10% (w/v) trichlo-
roacetic acid (TCA) to precipitate proteins. The precipi-
tate was pelleted by centrifugation. The results were ex-
pressed as mmol/L of plasma according to a standard
graphic, which was prepared with serial dilutions of stan-
dard 1,1,3,3-tetramethoxypropane. The TBA and TCA
used in this assay procedure were obtained from Sigma
Chemical Company.
Hemoglobin (Hb) concentrations were determined by
the method of Drabkin.
Measurement of erythrocyte CuZn-SOD activity was
performed using Ransod reagents (Randox Laboratories)
and is based on the method developed by McCord and
Fridovich18. Absorbance was monitored in a Beckman
DU 7500 spectrophotometer19.
GSH levels were determined on erythrocyte lysate af-
ter precipitation of proteins, using Ellman,s reagent.
Cayman’s GSH assay kit utilizes a carefully optimized
enzymatic recycling method, using glutathione reductase
for the quantification of GSH. The sulfhydryl group of
GSH reacts with DTNB (5.5-diothio-bis-2-nitrobenzoic
acid) and produces a yellow colored 5-thio-2-nitrobenzoic
acid (TNB). The mixed disulfide, GSTNB (between GSH
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and TNB) that is concomitantly produced, is reduced by
glutathione reductase to recycle the GSH and produce
more TNB. The rate of TNB production is directly propor-
tional to this recycling reaction which in turn is directly
proportional to the concentration of GSH in the sample19.
Measurement of erythrocyte glutathione peroxidase
(GSH-Px) activity was performed using the Cayman Che-
mical Glutathione Peroxidase Assay Kit. The activity of
GPx was measured indirectly by a coupled reaction with
glutathione reductase (GR). Oxidized glutathione (GSSG),
produced upon reduction of hydroperoxide by GPx, is re-
cycled to its reduced state by GR and NADPH. The oxi-
dation of NADPH to NADP+ is accompanied by a de-
crease in absorbance at 340 nm. Under conditions in
which the GPx activity is rate limiting, the rate of de-
crease in the A340 is directly proportional to the GPx ac-
tivity in the sample20.
Measurement of erythrocyte glutathione reductase
(GR) activity was performed using the Cayman Chemical
Glutathione Reductase Assay Kit. The activity of GR was
measured by the rate of NADPH oxidation. The oxida-
tion of NADPH to NADP+ is accompanied by a decrease
in absorbance at 340 nm and is directly proportional to
the GR activity in the sample21.
Investigated erythrocyte antioxidant defence: super-
oxide dismutase (SOD), glutathione peroxidase (GSH-Px),
glutathione (GSH) and glutathione reductase (GR) and
their activity is expressed as IU/g Hb.
Results
Results of plasma MDA, as a measure of lipid pero-
xidation, and erythrocyte antioxydant activity of SOD,
GR and GSH-Px, and concentration of GSH and MDA in
healthy children and children with asthma were pre-
sented in Table 1.
Assessed plasma MDA level showed no statistically
significant difference in group of children with asthma
compared with control group (p>0.05). But, erythrocyte
GSH-Px activity was significantly lower in the group of
children with asthma than in control group (3.99±0.98
IU/g Hb vs. 4.61±1.35 IU/g Hb; p=0.034). Determined
erythrocyte SOD activity and also activity of GR and con-
centration of GSH showed no statistically significant dif-
ference between studied groups of children (p>0.05).
Discussion
The lung is a major target organ for injury by exoge-
nous oxidants such as environmental pollutants (house
dust mite). Many environmental pollutants (Dermato-
phagoides pteronyssinus) exert their major effect by cau-
sing asthma and oxidative stress in cells and tissues that
they contact. Reactive oxygen species (ROS) may damage
proteins, lipids, and DNA directly22,23. Oxidants can cau-
se airway inflammation and airway hyperresponsive-
ness, which are major characteristics of asthma. Patients
with asthma have increased ROS production24.
The hydroxyl radical is, by far the most damaging
ROS and reacts with biomolecules primarily by hidrogen
abstraction and addition reactions. Characteristic prod-
ucts, described as biomarkers of oxidative stress, are
formed in these reactions. One of the most sensitive sites
of free radical damage is the cell membrane, which is rich
in readily oxidized polyunsaturated fatty acids. Peroxi-
dative damage of cell membranes affects the integrity
and function of the membrane, compromising cell’s abil-
ity to maintain ion gradients and membrane phospho-
lipids asymmetry. Lipid peroxides formed in this reaction
degrade to form characteristic products, such as malon-
dialdehyde (MDA)25.
In the study of Jacobson et al. investigated plasma
MDA level was higher in asthma subjects (1.30±0.6 mmol/L)
than in controls (0.86±0.5 mmol/L), but patients in this
study have acute severe asthma26. But, in the study of
Hanta et al. result was quite opposite. MDA was lower in
the asthmatic group than in the healthy subjects27. In
this study the oxidant-antioxidant balance was investi-
gated in mild asthmatic adult patients. Our results of
MDA level in asthmatic children may be explained by
controlled status of disease in time of sampling.
Study of Sackesen et al. showed decreased GSH-Px
activity in children patients with mild asthma in chil-
dren8. The children in this study were not receiving any
controller medication and had not any symptoms of re-
spiratory infection or asthma exacerbation. The same re-
sult was achieved in our study, GSH-Px was lower and
statistically significant in children with controlled asthma
than in controls (p=0.034).
Chronic oxidative stress in red blood cells (RBC) re-
sults in a significantly increase GSH concentration with
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TABLE 1
PLASMA MDA AND ERYTHROCYTE ANTIOXIDANT STATUS IN CHILDREN WITH CONTROLLED ASTHMA AND HEALTHY SUBJECT
Control group
(healthy children, n=37) X±SD
Patient group
(children with asthma, n=44) X±SD
p-value*
MDA, mmol/L 1.23±1.0 0.97±0.6 0.154
GSH, nmol/g Hb 202.9±18.4 204.6±14.1 0.939
GSH-Px, IU/g Hb 4.61±1.3 3.99±1.0 0.034
SOD, IU/g Hb 26.15±2.9 25.77±3.9 0.825
GR, IU/g Hb 0.44±0.3 0.36±0.2 0.212
* t-test
a concomitantly decreased GSSG level28. In our study,
erythrocyte GSH level was slightly increased in the chil-
dren group with asthma vs. control group and this result
was not statistically significant (p>0.05) (Table 1). Other
authors like, Ercan et al. showed that glutathione is sig-
nificantly decreased in asthma subjects7.
GSH-Px reduces hydrogen peroxide and lipid perox-
ide, using GSH as a co-substrate. The GSH is recycled by
glutathione-reductase (GR) using NADPH from the pen-
tose phosphate pathway. This enzyme is essential for the
GSH redox cycle which maintains adequate levels of re-
duced cellular GSH. A high GSH/GSSG ratio is essential
for protection against oxidative stress. Superoxide is one
of the main in the cell and as such, SOD serves a key an-
tioxidant role. SOD is the major superoxide dismutase of
pulmonary fluids and interstitial spaces of the lungs26–28.
Our preliminary results showed that only one (GSH-Px)
of all studied parameters was harmed in studied asthma-
tic children group. But, further investigation is needed to
evaluate antioxydant/oxydant balance in asthma and also
by disease duration and definitive conclusions of oxida-
tive stress role in pathogenesis of asthma.
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MDA I ERITROCITNI ANTIOKSIDACIJSKI STATUS KOD DJECE S KONTROLIRANOM ASTMOM
S A @ E T A K
U patogenezi astme, oksidativni stres i postojanje oksidacijsko/antioksidacijske neravnote`e imaju va`nu ulogu. U
ovoj studiji analizirana je uloga biljega oksidativnog stresa i lipidne peroksidacije u patogenezi astme dje~je dobi u
usporedbi sa zdravim ispitanicima iste dobi. Plazmatski biljeg lipidne peroksidacije malondialdehid (MDA), antioksida-
cijski enzimi iz eritrocita: glutation peroksidaza (GSH-Px), superoksid dismutaza (SOD), glutation reduktaza (GR) i
glutation (GSH), odre|eni su spektrofotometrijskom metodom iz uzoraka krvi sakupljenih od 37 zdrave djece i 44 djece
s kontroliranom astmom. Rezultati su pokazali signifikantno ni`u aktivnost GSH-Px u skupini djece s kontroliranom
astmom (3.99±1.0 IU/gHb) u usporedbi s kontrolnom skupinom (4.61±1.3 IU/gHb; p<0.034). Zna~ajne razlike u aktiv-
nosti SOD, GR, GSH i MDA nisu potvr|ene (p>0.05). Ni`a aktivnost GSH-Px u skupini djece s kontroliranom astmom
ukazuje na smanjeni eritrocitni antioksidacijski status i ukazuje na povezanost izme|u oksidativnog stresa i astme u
ispitivanoj skupini. Me|utim, sa~uvana aktivnost GR, SOD te koncentracija GSH i MDA ~ini se odlu~uju}a u kontroli
oksidacijsko/antioksidacijske ravnote`e.
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